• Issue

    Muscle & Nerve: Volume 72, Issue 2

    179-345
    August 2025
Previous Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • First Published: 26 July 2025

INVITED REVIEW

Management Approaches to Spastic Gait Disordersimage

Sheng Li,  Tulsi Pandat,  Bradley Chi,  Daniel Moon,  Manuel Mas, 
  • Pages: 179-200
  • First Published: 08 April 2025

Chronic Inflammatory Demyelinating Polyneuropathy: How Pathophysiology Can Guide Treatmentimage

Karissa L. Gable,  Yingkai Li, 
  • Pages: 201-211
  • First Published: 20 May 2025

ISSUES AND OPINIONS

Educating the Next Generation of Neuromuscular and Electrodiagnostic Practitioners: Challenges and Opportunities

Lawrence R. Robinson, 
  • Pages: 212-216
  • First Published: 27 May 2025

CLINICAL RESEARCH ARTICLE

Open Access

The Role of Repeat Skeletal Muscle Biopsy: Indications, Yield and Outcomes

Thomas Khoo,  Sarah Saxon,  Barbara Koszyca,  Bernice Gutschmidt,  Vidya Limaye, 
  • Pages: 217-223
  • First Published: 02 May 2025
Open Access

Frequency of Guillain-Barré Syndrome During the COVID-19 Pandemic: A Multicenter Study

Toshiyuki Hayashi,  Tatsushi Toda,  Atsuro Chiba,  Nobutaka Hattori,  Masahiro Sonoo,  Hideto Nakajima,  Takanori Yokota,  Yasuyuki Iguchi,  Hidetomo Murakami,  Haruhisa Kato,  Osamu Kano,  Kazuo Kitagawa,  Satoshi Kitagawa,  Hiroshi Nagayama,  Kazumi Kimura, 
  • Pages: 224-229
  • First Published: 05 May 2025
Open Access

Switching Enzyme Replacement Therapy for Late-Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL

Hani Kushlaf,  Jordi Díaz-Manera,  Drago Bratkovic,  Barry J. Byrne,  Kristl G. Claeys,  Paula R. Clemens,  Mazen M. Dimachkie,  Priya S. Kishnani,  Pascal Laforêt,  Mark Roberts,  Benedikt Schoser,  Antonio Toscano,  Jeff Castelli,  Fred Holdbrook,  Sheela Sitaraman Das,  Mitchell Goldman,  Tahseen Mozaffar,  on behalf of the PROPEL Study Group , 
  • Pages: 230-239
  • First Published: 07 May 2025
Switching Enzyme Replacement Therapy for Late-Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL

A total of 95 ERT-experienced adults with LOPD were randomized to switch to cipaglucosidase alfa + miglustat or remain on alglucosidase alfa treatment. After 52 weeks, patients remaining on alglucosidase alfa showed worsening or stability for most outcomes, whereas patients who switched to cipaglucosidase alfa + miglustat generally showed stability or improvement.

Serum Creatine Kinase and Transaminase Levels in Duchenne and Becker Muscular Dystrophies

Marie Rohlenová,  Kateřina Machová,  Jana Baranová,  Lenka Mokrá,  Livie Mensová,  Radim Mazanec,  Lenka Juříková,  Jan Staněk,  Petra Fuchsová,  Barbora Lauerová,  Markéta Kumhera,  Jana Haberlová, 
  • Pages: 240-249
  • First Published: 11 May 2025
Open Access

Mycophenolate Facilitates Improvement in Outcome Measures in Treatment Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Shamim Miah,  Nicole Japzon,  Amar Elsaddig,  Shiwen Koay,  Laura Compton,  Michael P. Lunn,  Aisling S. Carr, 
  • Pages: 250-257
  • First Published: 13 May 2025

Nerve Ultrasound for Detecting Morphologic Changes in Malnourished Children Under 5 Years of Age: A Comparative Study of Nutritional Intervention Outcomes in Bangladesh

Nurun Nahar Naila,  Aklima Alam,  Gobinda Karmakar,  M. Munirul Islam,  Tahmeed Ahmed,  Badrul Islam, 
  • Pages: 258-266
  • First Published: 14 May 2025

Quinine Sulfate for Muscle Cramps in Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind Crossover Trial

Charlotte Vogt,  Markus Weber,  Ursula Schneider,  Christoph Neuwirth, 
  • Pages: 267-273
  • First Published: 19 May 2025
Open Access

Quality of Life of People With Neuromuscular Diseases: The Role of Stigma

Marion Sommers-Spijkerman,  Esther Kruitwagen-van Reenen,  Willeke Kruithof,  Johanna M. A. Visser-Meily,  Eline Scholten,  Anita Beelen, 
  • Pages: 274-285
  • First Published: 19 May 2025
Open Access

Peripheral Nervous System Involvement of Hereditary Transthyretin Amyloidosis in the United States: A Multi-Center Perspective

Urvi Desai,  Hristelina S. Ilieva,  James E. Eyer,  Amanda C. Peltier, 
  • Pages: 286-293
  • First Published: 20 May 2025
Open Access

Operational Development and Launch of an Adaptive Platform Trial in Amyotrophic Lateral Sclerosis: Processes and Learnings From the First Four Regimens of the HEALEY ALS Platform Trial

Brittney A. Harkey,  Sofia Distefano,  Jaclyn A. Pagliaro,  Lindsay Heyd,  Marianne Chase,  Courtney Igne,  Hong Yu,  Alexander V. Sherman,  Derek Dagostino,  Eric Tustison,  Genevive Changkuon,  Meghan Hall,  Gale Kittle,  Mariah R. Connolly,  Elisa Giacomelli,  Erica Scirocco,  James D. Berry,  Suma Babu,  Jeremy Shefner,  Eric A. Macklin,  Lori B. Chibnik,  Annette De Mattos,  Kristin Drake,  Cornelia Kamp,  Andrew McGarry,  Margherita Torti,  Catherine Small,  Allison Bulat,  Merit E. Cudkowicz,  Sabrina Paganoni,  for the HEALEY ALS Platform Trial Study Group , 
  • Pages: 294-305
  • First Published: 26 May 2025
Open Access

Function of the Normal Neuromuscular Junction in Young Children

Márk Kozák,  Katalin Szatmári,  Erzsébet Németh,  Béla Fülesdi,  Attila Nagy,  Attila Tóth,  Judit Boczán, 
  • Pages: 306-312
  • First Published: 28 May 2025
Open Access

Measuring Adverse Event Burden in Myasthenia Gravis: Retrospective Validation of the Adverse Event Unit With Randomized Trial of Thymectomy in Myasthenia Gravis Data

Michael K. Hehir,  Inmaculada B. Aban,  Henry J. Kaminski, 
  • Pages: 313-320
  • First Published: 02 June 2025

CLINICAL RESEARCH SHORT REPORT

A Preliminary Investigation of Acoustic Features for Remote Monitoring of Respiration in ALS

Kathryn P. Connaghan,  Marziye Eshghi,  Abigail E. Haenssler,  Jordan R. Green,  Joycelyn Wang,  Zoe Scheier,  Mackenzie Keegan,  Alison Clark,  Jukka-Pekka Onnela,  Katherine M. Burke,  James D. Berry, 
  • Pages: 321-326
  • First Published: 14 May 2025

Efgartigimod Is an Effective Treatment for Triple-Seronegative Generalized Myasthenia Gravis: A Report of Three Patients

Jingyi Shen,  Chi Ma,  Ying Zhu,  Ruixia Zhu, 
  • Pages: 327-330
  • First Published: 20 May 2025

Body Composition in Children With Spinal Muscular Atrophy Types 2 and 3 Receiving Nusinersen Treatment: A Longitudinal Cohort Study

Yue Yan,  Xinli Zou,  Dongming Zhou,  Danhui Zhu,  Yijie Feng,  Yicheng Yu,  Jianing Jin,  Qi Long,  Yuzhi Chen,  Fei Chen,  Feng Gao,  Shanshan Mao, 
  • Pages: 331-335
  • First Published: 22 May 2025

LETTER TO THE EDITOR

Details Matter: The Difference Between NIV and NVS

Kelli Gaul-Muller,  John R. Bach, 
  • Pages: 336-337
  • First Published: 07 April 2025

REPLY

Response to the Letter From Gaul-Muller and Bach on NIV Intolerance, NIV Settings and Mortality in MND Patients With Gastrostomy

Jie Yang,  Svein Van Oyen,  Merrilee Needham,  Emily Calton, 
  • Pages: 338-339
  • First Published: 13 June 2025

SOCIETY INFORMATION

AANEM News & Insights

  • Pages: 340-343
  • First Published: 26 July 2025

Calendar of Events

  • Page: 344
  • First Published: 26 July 2025

Join AANEM

  • Page: 345
  • First Published: 26 July 2025